CaÑada, Baby Girl N.
HRN: 212275 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/25/2022
05/01/2022
IV
40mg
Q24H
PSNB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes